Abstract
Nanotechnology is the manipulation of matter in dimensions <100nm. At this size, matter can take on different chemical and physical properties, giving the products characteristics useful to industry, medicine and technology. Government funding and private investors provide billions of research dollars for the development of new materials and applications. The potential utility of these technologies is such that they are expected be a trillion-dollar industry within the next 10 years.
However, the novel properties of nanoengineered materials lead to the potential for different toxicity compared with the bulk material. The field of nanotoxicology is still in its infancy, however, with very limited literature regarding potential health effects. Inhalational toxicity is to be expected, given the known effects of inhaled fine particulate matter. However, the degree to which most nanoparticles will aerosolise remains to be determined. It has been proposed that dermal exposure will be the most relevant route of exposure, but there is considerably less literature regarding dermal effects and absorption. Less defined still are the potential effects of nanoproducts on fetal development and the environment.
Similar content being viewed by others
References
Lin H, Datar RH. Medical applications of nanotechnology. Natl Med J India 2006; 19(1): 27–32
Joy B. Why the future doesn’t need us. Wired 2000; 8.04: 1–11
Iijima S. Helical microtubules of graphitic carbon. Nature 1991; 354: 56–8
Gogotsi Y. How safe are nanotubes and other nanofilaments? Mat Res Innov 2003; 7: 192–4
Lam CW, James JT, McCluskey R, et al. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004; 77(1): 126–34
Chan WC, Maxwell DJ, Gao X, et al. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 2002; 13(1): 40–6
Hoshino A. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 2004; 4(11): 2163–9
Hanaki K, Momo A, Oku T, et al. Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. Biochem Biophys Res Commun 2003; 302(3): 496–501
Akerman ME, Chan WC, Laakkonen P, et al. Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A 2002; 99(20): 12617–21
Han M, Gao X, Su JZ, et al. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol 2001; 19(7): 631–5
Office of the Press Secretary. National nanotechnology initiative: leading to the next industrial revolution [online]. Available from URL: http://clinton4.nara.gov/textonly/WH/New/html/20000121_4.html [Accessed 2006 Aug 18]
Guzman KA, Taylor MR, Banfield JF. Environmental risks of nanotechnology: National Nanotechnology Initiative funding, 2000–2004. Environ Sci Technol 2006; 40(5): 1401–7
Salamanca-Buentello F, Persad DL, Court EB, et al. Nanotechnology and the developing world. PLoS Med 2005; 2(5): e97
Hsiao JC, Fong K. Making big money from small technology. Nature 2004; 428(6979): 218–20
Triendl R. Breaking down biological borders. Nature 2002; 418(6899): 7
Aitken RJ, Chaudhry MQ, Boxall AB, et al. Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med (Lond) 2006; 56(5): 300–6
Milunovich S, Roy JMA, Fan Z-H. Nanotechnology: introducing the Merrill Lynch Nanotech Index [online]. Available from URL: http://www.ml.com/media/42322.pdf [Accessed 2007 Jan 11]
Brumfiel G. Consumer products leap aboard the nano bandwagon. Nature 2006; 440(7082): 262
Lemley MA. Patenting nanotechnology. Stanford Law Rev 2005; 58(2): 601–30
Whatmore RW. Nanotechnology: what is it? Should we be worried? Occup Med (Lond) 2006; 56(5): 295–9
Vandorpe J, Schacht E, Dunn S, et al. Long circulating biodegradable poly (phosphazene) nanoparticles surface modified with poly (phosphazene)-poly (ethylene oxide) copolymer. Biomaterials 1997; 18(17): 1147–52
Garnett MC, Kallinteri P. Nanomedicines and nanotoxicology: some physiological principles. Occup Med (Lond) 2006; 56(5): 307–11
Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989; 6(3): 193–210
Porter CJ, Moghimi SM, Ilium L, et al. The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett 1992; 305(1): 62–6
Lind K, Kresse M, Debus NP, et al. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour. J Drug Target 2002; 10(3): 221–30
Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001; 47(1): 65–81
Pantarotto D, Briand JP, Prato M, et al. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb) 2004; (1): 16–7
Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348(25): 2491–9
Bruchez M, Moronne M, Gin P, et al. Semiconductor nanocrystals as fluorescent biological labels. Science 1998; 281(5385): 2013–6
Steiniger SCJ, Kreuter J, Khalansky AS, et al. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 2004; 109(5): 759–67
Michaelis K, Hoffmann MM, Dreis S, et al. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 2006; 317(3): 1246–53
Zheng G, Patolsky F, Cui Y, et al. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat Biotechnol 2005; 23(10): 1294–301
Donaldson K, Stone V, Clouter A, et al. Ultrafine particles. Occup Environ Med 2001; 58(3): 211–6, 199
Peters A, Wichmann HE, Tuch T, et al. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med 1997; 155(4): 1376–83
Dockery DW, Pope CA, Xu X, et al. An association between air pollution and mortality in six US cities. N Engl J Med 1993; 329(24): 1753–9
Dockery DW. Epidemiologic evidence of cardiovascular effects of particulate air pollution. Environ Health Perspect 2001; 109Suppl. 4: 483–6
Pope CA, Dockery DW. Acute health effects of PM10 pollution on symptomatic and asymptomatic children. Am Rev Respir Dis 1992; 145(5): 1123–8
Xu B, Xia M, Deng Y, et al. Nanotechnology and nanoparticles and their advances of investigation and application in the fields of biomedicine [in Chinese]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2004; 21(2): 333–6
Dockery DW, Luttmann-Gibson H, Rich DQ, et al. Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators. Environ Health Perspect 2005; 113(6): 670–4
Franklin M, Zeka A, Schwartz J. Association between PM (2.5) and all-cause and specific-cause mortality in 27 US communities. J Expo Sci Environ Epidemiol 2006 [Epub ahead of print]
Brown DM, Stone V, Findlay P, et al. Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup Environ Med 2000; 57(10): 685–91
Renwick LC, Brown D, Clouter A, et al. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med 2004; 61(5): 442–7
Warheit DB, Webb TR, Sayes CM, et al. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol Sci 2006; 91(1): 227–36
Beckett WS, Chalupa DF, Pauly-Brown A, et al. Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med 2005; 171(10): 1129–35
Brown JS, Zeman KL, Bennett WD. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 2002; 166(9): 1240–7
Geiser M, Rothen-Rutishauser B, Kapp N, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005; 113(11): 1555–60
Beck-Speier I, Dayal N, Karg E, et al. Agglomerates of ultrafine particles of elemental carbon and TiO2 induce generation of lipid mediators in alveolar macrophages. Environ Health Perspect 2001; 109Suppl. 4: 613–8
Gavett SH, Madison SL, Dreher KL, et al. Metal and sulfate composition of residual oil fly ash determines airway hyperreactivity and lung injury in rats. Environ Res 1997; 72(2): 162–72
Dreher KL, Jaskot RH, Lehmann JR, et al. Soluble transition metals mediate residual oil fly ash induced acute lung injury. J Toxicol Environ Health 1997; 50(3): 285–305
Ghio AJ, Cohen MD. Disruption of iron homeostasis as a mechanism of biologic effect by ambient air pollution particles. Inhal Toxicol 2005; 17(13): 709–16
Mossman BT, Bignon J, Corn M, et al. Asbestos: scientific developments and implications for public policy. Science 1990; 247(4940): 294–301
Brown RC, Hoskins JA, Miller K, et al. Pathogenetic mechanisms of asbestos and other mineral fibres. Mol Aspects Med 1990; 11(5): 325–49
Magrez A, Kasas S, Salicio V, et al. Cellular toxicity of carbon-based nanomaterials. Nano Lett 2006; 6(6): 1121–5
Gaensler EA, Cadigan JB, Sasahara AA, et al. Graphite pneumoconiosis of electrotypers. Am J Med 1966; 41(6): 864–82
Oberdorster G. Determinants of the pathogenicity of man-made vitreous fibers (MMVF). Int Arch Occup Environ Health 2000; 73 Suppl.: S60–8
Hesterberg TW, Chase G, Axten C, et al. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol 1998; 151(2): 262–75
Hesterberg TW, Hart GA, Chevalier J, et al. The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats. Toxicol Appl Pharmacol 1998; 153(1): 68–82
Hesterberg TW, Miiller WC, Musselman RP, et al. Biopersistence of man-made vitreous fibers and crocidolite asbestos in the rat lung following inhalation. Fundam Appl Toxicol 1996; 29(2): 267–79
Shvedova AA, Kisin ER, Mercer R, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005; 289(5): L698–708
Warheit DB, Laurence BR, Reed KL, et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 2004; 77(1): 117–25
Muller J, Huaux F, Moreau N, et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 2005; 207(3): 221–31
Inoue K, Takano H, Yanagisawa R, et al. Effects of nano particles on antigen-related airway inflammation in mice. Respir Res 2005; 6: 106
Jia G, Wang H, Yan L, et al. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 2005; 39(5): 1378–83
Baron PA, Maynard AD, Foley M. Evaluation of aerosol release during the handling of unrefined single walled carbon nanotube material. Cincinnati (OH): National Institute for Occupational Safety and Health, 2002 Dec. NIOSH report: DART-02-191
Maynard AD, Baron PA, Foley M, et al. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A 2004; 67(1): 87–107
Masciangioli T, Zhang WX. Environmental technologies at the nanoscale. Environ Sci Technol 2003; 37(5): 102A–8A
Sayes CM, Gobin AM, Ausman KD, et al. Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 2005; 26(36): 7587–95
Sayes C, Fortner J, Lyon D, et al. The differential cytotoxicity of water soluble fullerenes. Nano Lett 2004; 4: 1881–7
Nelson MA, Domann FE, Bowden GT, et al. Effects of acute and subchronic exposure of topically applied fullerene extracts on the mouse skin. Toxicol Ind Health 1993; 9(4): 623–30
Monteiro-Riviere NA, Nemanich RJ, Inman AO, et al. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005; 155(3): 377–84
Ding L, Stilwell J, Zhang T, et al. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett 2005; 5(12): 2448–64
Shvedova AA, Castranova V, Kisin ER, et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 2003; 66(20): 1909–26
Manna SK, Sarkar S, Barr J, et al. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. Nano Lett 2005; 5(9): 1676–84
Huczko AL, Lange H. Carbon nanotubes: experimental evidence for a null risk of skin irritation and allergy. Fullerene Sci Technol 2001; 9(2): 247–50
Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 2006; 91(1): 159–65
Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol. Epub 2006 Aug 10
Lademann J, Weigmann H, Rickmeyer C, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 1999; 12(5): 247–56
Schulz J, Hohenberg H, Pflucker F, et al. Distribution of sunscreens on skin. Adv Drug Deliv Rev 2002; 54Suppl. 1: S157–63
Lam PK, Chan ES, Ho WS, et al. In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. Br J Biomed Sci 2004; 61(3): 125–7
Chen Z, Meng H, Xing G, et al. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 2006; 163(2): 109–20
Chen HH, Yu C, Ueng TH, et al. Acute and subacute toxicity study of water-soluble polyalkylsulfonated C60 in rats. Toxicol Pathol 1998; 26(1): 143–51
Yamago S, Tokuyama H, Nakamura E, et al. In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol 1995; 2(6): 385–9
Tsuchiya T, Oguri I, Yamakoshi YN, et al. Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo. FEBS Lett 1996; 393(1): 139–45
Rajagopalan P, Wudl F, Schinazi RF, et al. Pharmacokinetics of a water-soluble fullerene in rats. Antimicrob Agents Chemother 1996; 40(10): 2262–5
Hillyer JF, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001; 90(12): 1927–36
Oberdorster G, Sharp Z, Atudorei V, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004; 16(6–07): 437–45
Oberdorster E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 2004; 112(10): 1058–62
Zhu S, Oberdorster E, Haasch ML. Toxicity of an engineered nanoparticle (fullerene, C60) in two aquatic species, Daphnia and fathead minnow. Mar Environ Res 2006; 62 Suppl.: S5–9
Wang H, Wang J, Deng X, et al. Biodistribution of carbon single-wall carbon nanotubes in mice. J Nanosci Nanotechnol 2004; 4(8): 1019–24
Yamawaki H, Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol 2006; 290(6): C1495–502
Kirchner C, Liedl T, Kudera S, et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett 2005; 5(2): 331–8
Derfus AM, Chan WCW, Bahtia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004; 4(1): 11–8
Bottini M, Bruckner S, Nika K, et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett 2006; 160(2): 121–6
Pantarotto D, Partidos CD, Graff R, et al. Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides. J Am Chem Soc 2003; 125(20): 6160–4
Pantarotto D, Partidos CD, Hoebeke J, et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol 2003; 10(10): 961–6
Chen BX, Wilson SR, Das M, et al. Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. Proc Natl Acad Sci U S A 1998; 95(18): 10809–13
Zakharenko LP, Zakharov IK, Vasiunina EA, et al. Determination of the genotoxicity of fullerene C60 and fullerol using the method of somatic mosaics on cells of Drosophila melanogaster wing and SOS-chromotest [in Russian]. Genetika 1997; 33(3): 405–9
Babynin EV, Nuretdinov IA, Gubskaia VP, et al. Study of mutagenic activity of fullerene and some of its derivatives using His+ reversions of Salmonella typhimurium as an example [in Russian]. Genetika 2002; 38(4): 453–7
Sera N, Tokiwa H, Miyata N. Mutagenicity of the fullerene C60-generated singlet oxygen dependent formation of lipid peroxides. Carcinogenesis 1996; 17(10): 2163–9
Tsuchiya T, Yamakoshi YN, Miyata N. A novel promoting action of fullerene C60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem Biophys Res Commun 1995; 206(3): 885–94
Zheng M, Jagota A, Semke ED, et al. DNA-assisted dispersion and separation of carbon nanotubes. Nat Mater 2003; 2(5): 338–42
Green M, Howman E. Semiconductor quantum dots and free radical induced DNA nicking. Chem Commun (Camb) 2005; (1): 121–3
Lu ZX, Zhang ZL, Zhang MX, et al. Core/shell quantum-dot-photosensitized nano-TiO (2) films: fabrication and application to the damage of cells and DNA. J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 2005; 109(47): 22663–6
Braydich-Stolle L, Hussain S, Schlager JJ, et al. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005; 88(2): 412–9
ETC-Group. No small matter II: the case for a global moratorium. Size matters! Ottawa: ETC Group, 2003
Owen R, Depledge M. Nanotechnology and the environment: risks and rewards. Mar Pollut Bull 2005; 50(6): 609–12
Powell K. Green groups baulk at joining nanotechnology talks. Nature 2004; 432(7013): 5
Gaskell G, Ten Eyck T, Jackson J, et al. Public attitudes to nanotechnology in Europe and the United States. Nat Mater 2004; 3(8): 496
Giles J. Size matters when it comes to safety, report warns. Nature 2004; 430(7000): 599
Moore MN. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? Environ Int 2006 Dec; 32(8): 967–76
Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol 2003; 21(10): 1166–70
Oberdorster E, Zhu S, Blickley TM, et al. Ecotoxicology of carbon-based engineered nanoparticles: effects of fullerene (C60) on aquatic organisms. Carbon 2006; 44: 1112–20
Bergeson LL, Auerbach B. The Environmental regulatory implications of nanotechnology. Daily Environment Report No. 71. Washington, DC: Bureau of National Affairs Inc., 2004
Sharpe M. Small wonders, big future: the development of environmental nanotechnology. J Environ Monit 2006; 8(2): 235–9
Service RF. Nanotechnology: EPA ponders voluntary nanotechnology regulations [online]. Available from URL: http://www.sciencemag.org/cgi/content/full/sci;309/5731/36b [Accessed 2007 Jan 15]
US Environmental Protection Agency. Toxicology of particulate matter in humans and laboratory animals [online]. Available from URL: http://www.epa.gov/osa/pdfs/EPA_nanotechnology_white_paper_external_review-_draft_12-02-2005.pdf [Accessed 2007 Jan 15]
US Environmental Protection Agency. Air quality criteria for particulate matter [online]. Available from URL: http://cfpub.epa.gov/ncea/cfm/partmatt.cfm [Accessed 2007 Jan 15]
US Environmental Protection Agency. Particulate matter standards [online]. Available from URL: http://www.epa.gov/air/particlepollution/standards.html [Accessed 2006 Dec 13]
Dreher KL. Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles. Toxicol Sci 2004; 77(1): 3–5
US Department of Labor. Occupational Safety & Health Administration. Table Z-1 limits for air contaminants [online]. Available from URL: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=standard-s&p_id=9992 [Accessed 2007 Jan 11]
US Department of Labor. Occupational Safety & Health Administration. Table Z-2–1910 [online]. Available from URL: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=standards&p_id=9993 [Accessed 2007 Jan 11]
US Department of Labor. Occupational Safety & Health Administration. Table Z-3 mineral dusts [online]. Available from URL: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=standards&p_id=9994 [Accessed 2007 Jan 11]
Miller J. Beyond biotechnology: FDA regulation of nanomedicine. Columbia Sci Technol Law Rev 2003; 4: E5
Moore R. Standards in the 21st century: standardising new medical technologies, part I. Med Device Technol 2002; 13(9): 44–5
Acknowledgements
John Curtis, MD, reports that he was compensated for his time by Newfields, LLC, Atlanta, GA, USA. No other sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review. The authors would like to thank Benjamin Legum for his contributions to the review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Curtis, J., Greenberg, M., Kester, J. et al. Nanotechnology and Nanotoxicology. Toxicol Rev 25, 245–260 (2006). https://doi.org/10.2165/00139709-200625040-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00139709-200625040-00005